Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

Summary

Phase I trial to study genetic testing and the effectiveness of irinotecan in treating patients who have solid tumors and lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Genetic testing for a specific enzyme may help doctors determine whether side effects from or response to chemotherapy are related to a person's genetic makeup

Timeline

Start

1999-01

Primary completion

2003-10

Completion

—

Drugs

Indications